לקריאת מידע כללי לפי נושאים:


תה קולסטונית

 
 
 
Kolesteren tea contains -    Taraxacum (Dandelion), Silybum Marianum (Gadilan), Calendula, Lemon Verbena, Olive leaves, Hibiscus, Alfalfa, Plantago, Citrus, Pomegranate.

 

 

Seientific publications and more material about healing herbs

 

 

 

 

TARAXACUM (Dandelion)

 

 

 

 

Life Sciences, 2004 Jan. 16; 74(9): 1149-1157

 

Alternative Medicine Review, 1999 Apr.; 4(2): 112-114

 

Human and Experimental Toxicology, 1990 Jul.; 9(4): 235-244

 

ESCOP Taraxaci herba and Taraxaci radix. Monograph on the Medicinal Uses of Plant Drugs. Exeter, U.K. European Scientific Cooperative on Phytotherapy, 1997.

 

Hobbs C. Dandelion: A Monograph, Portland, OR, Eclectic Medicinal Publication, 1985.

 

Kuusi T. Pysalo H. Autio K. The bitterness of dandelion ll. Chemical investigations. Lebensum Wiss Technol. 18:347-349, 1985.

  

William CA. Goldstone F. Greenham J. Flavonoids, cinnamic acids and coumarins from the different tissues and medicinal preparations of Taraxacum officinalis. Phytochemistry, 42(1): 121-127, 1996.

 

Hook I. McGee A. Henman M. Evaluation of Dandelion for diuretic activity and variation in potassium content. Int. J. Pharmacog.  31:29-34, 1993.

 

Wichtl M. Herbal Drugs and Phytopharmaceuticals. Boca Raton, FL: CRC Press, 1994, 486–9

 

Bradley PR (ed). British Herbal Compendium, Vol 1. Bournemouth, Dorset, UK: British Herbal Medicine Association, 1992, 73–5.

 

Racz-Kotilla E, Racz G, Solomon A. The action of Taraxacum officinale extracts on body weight and diuresis of laboratory animals. Planta Med 1974:26:212–7.

 

Kuusi T, Pyylaso H, Autio K. The bitterness properties of dandelion. II. Chemical investigations. Lebensm-Wiss Technol 1985;18:347–9.

 

 Böhm K. Choleretic action of some medicinal plants. Arzneimittelforschung 1959;9:376–8.

 

Blumenthal M, Busse WR, Goldberg A, et al. (eds). The Complete Commission E Monographs: Therapeutic Guide to Herbal Medicines. Boston, MA: Integrative Medicine Communications, 1998, 119–20.

 

 Foster S. Herbs for Your Health. Loveland, CO: Interweave Press, 1996, 26–7.

  

Blumenthal M, Busse WR, Goldberg A, et al. (eds). The Complete Commission E Monographs: Therapeutic Guide to Herbal Medicines. Boston, MA: Integrative Medicine Communications, 1998, 118–9.

 

Blumenthal M, Busse WR, Goldberg A, et al. (eds). The Complete Commission E Monographs: Therapeutic Guide to Herbal Medicines. Boston, MA: Integrative Medicine Communications, 1998, 118–20.

 

Duke JA. Handbook of Phytochemical Constituents of GRAS Herbs and Other Economic Plants. Boca Raton, FL; CRC Press, 1992.

 

Carabin IG, Flamm WG. Evaluation of safety of inulin and oligofructose as dietary fiber. Regul Toxicol Pharmacol 1999;30:268–82.

 

Coussement PA. Inulin and oligofructose: safe intakes and legal status. J Nutr 1999;129:1412S–7S.

 

Gay-Crosier F, Schreiber G, Hauser C. Anaphylaxis from inulin in vegetables and processed food. N Engl J Med 2000;342:1372.

 

 

 

Silybum Marianum

 

 

Journal of Alternative and Complementary Medicine, 2003 Jun; 9 (3):411-466.

 

Gastroenterology Nursing, 2001 Mar.-Apr. 24 (2): 95-97.

 

Human and Experimental Toxicology, 1990 Jul.; 9 (4):235-244.

 

Wichtl, M.(1994), Herbal Drugs and Phytopharmaceuticals, Stuttgart: CRC Press Medpharm Scientific Publishers. 121 - 123.

  

Fiebig, M,. Wagner, H,.(1984), New antihepatotoxic effects of flavonolingnans of white flowering variety of Silybum. Planta Med. 50, 310 – 313.

 

Hikino H, Kiso Y, Wagner H, Fiebig M. Antihepatotoxic actions of flavonolignans from Silybum marianum fruits. Planta Medica 1984;50:248–50.

 

Faulstich H, Jahn W, Wieland T. Silibinin inhibition of amatoxin uptake in the perfused rat liver. Arzneim-Forsch Drug Res 1980;30:452–4.

 

Tuchweber B, Sieck R, Trost W. Prevention by silibinin of phalloidin induced hepatotoxicity. Toxicol Appl Pharmacol 1979;51:265–75.

 

Feher J, Lang I, Deak G, et al. Free radicals in tissue damage in liver diseases and therapeutic approach. Tokai J Exp Clin Med 1986;11:121–34.

 

Gastroenterology, 1982; 17:417-421

 

Sonnenbichler J, Zetl I. Stimulating influence of a flavonolignan derivative on proliferation, RNA synthesis and protein synthesis in liver cells. In Assessment and Management of Hepatobiliary Disease, ed. L Okolicsanyi, G Csomos, G Crepaldi. Berlin: Springer-Verlag, 1987, 265–72.

 

Schuppan D, Strösser W, Burkard G, Walosek G. Legalon® lessens fibrosing activity in patients with chronic liver diseases. Zeits Allgemeinmed 1998;74:577–84.

 

Salmi HA, Sama S. Effect of silymarin on chemical, functional and morphological alterations of the liver. Scand J Gastroenterol 1982;17:517–21.

 

Leng-Peschlow E. Alcohol-related liver diseases-use of Legalon®. Z Klin Med 1994;2:22–7.

  

Ferenci P, Dragosics B, Dittrich H, et al. Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver. J Hepatol 1989;9:105–13.

 

Velussi M, Cernogoi AM, De Monte A, et al. Long-term (12 months) treatment with an antioxidant drug (silymarin) is effective on hyperinsulinemia, exogenous insulin need and malondialdehyde levels in cirrhotic diabetic patients. J Hepatology 1997;26:871–9.

 

Pares A, Plancs R, Torres M, et al. Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial. J Hepatol 1998;28:615–21.

 

Nassuato G, Iemmolo RM, Strazzabosco M, et al. Effect of silibinin on biliary lipid composition. Experimental and clinical study. J Hepatol 1991;12:290–5.

 

Palasciano G, Portinascasa P, Palmieri V, et al. The effect of silymarin on plasma levels of malondialdehyde in patients receiving long-term treatment with psychotropic drugs. Curr Ther Res 1994;S5:S37–45.

 

Allain H, Schück S, Lebreton S, et al. Aminotransferase levels and silymarin in de novo tacrine-treated patients with Alzheimer’s disease. Dementia Geriatr Cogn Disorders 1999;10:181–5.

 

Brown DJ. Herbal Prescriptions for Better Health. Rocklin, CA: Prima Publishing, 1996, 151–8.

 

Reyes H. The spectrum of liver and gastrointestinal disease seen in cholestasis of pregnancy. Gastroert Clin N Am 1992;21:905–21.

 

Adverse Drug Reactions Advisory Committee. An adverse reaction to the herbal medication milk thistle (Silybum marianum). MJA 1999;170:218–9.

 

 

 

 Calendula

 

 

Bashir S, Janbaz KH, Jabeen Q, Gilani AH. Studies on spasmogenic and spasmolytic activities of Calendula officinalis flowers.

Phytother Res. 2006 Aug 14

  

Jimenez-Medina E, Garcia-Lora A, Paco L, Algarra I, Collado A, Garrido F. A new extract of the plant Calendula Officinalis produces a dual in vitro effect: cytotoxic anti-tumor activity and lymphocyte activation.

BMC Cancer. 2006 May 5;6:119.

 

Barajas-Farias LM, Perez-Carreon JI, Arce-Popoca E, Fattel-Fazenda S, Aleman-Lazarini L, Hernandez-Garcia S, Salcido-Neyoy M, Cruz-Jimenez FG, Camacho J, Villa-Trevino S. A dual and opposite effect of Calendula officinalis flower extract: chemoprotector and promoter in a rat hepatocarcinogenesis model.

Planta Med. 2006 Feb;72(3):217-21.

 

Ferreyra CF, Ortiz CS. Simultaneous determination of bifonazole and tinctures of calendula flower in pharmaceutical creams by reversed-phase liquid chromatography.

J AOAC Int. 2005 Nov-Dec;88(6):1649-54.

 

Duran V, Matic M, Jovanovc M, Mimica N, Gajinov Z, Poljacki M, Boza P. Results of the clinical examination of an ointment with marigold (Calendula officinalis) extract in the treatment of venous leg ulcers.

Int J Tissue React. 2005;27(3):101-6.

 

Luten JD, Boyd L, Hanson MB, Lillie D, Gullion C, Madden TE. A clinical study: Melaleuca, Manuka, Calendula and green tea mouth rinse.

Phytother Res. 2005 Nov;19(11):951-7.

 

Kishimoto S, Maoka T, Sumitomo K, Ohmiya A. Analysis of carotenoid composition in petals of calendula (Calendula officinalis L.). Biosci Biotechnol Biochem. 2005 Nov;69(11):2122-8

 

Ciardullo AV. Calendula and thermal baths for treating a high-grade iatrogenic disability.

J Altern Complement Med. 2005 Oct;11(5):787. 

 

 

 

 

Olive Leaves

 

 

 

Phytomedicine, 2004 Feb.; 11 (2-3): 121-129.

 

Planta Medica, 1992 Dec.; 58 (6): 513-515.

 

Visioli F. and Gali C. Oleuropein protects low density lipoprotein from oxidation. Life Science 55: 1965-1971, 1994.

 

Tassou CC. Nychas GJE. Board RG. Effect of phenolic  compounds and oleuropein on the germination of Bacillus cereus T. spores Biotechnology Applied Biochemistry 13: 231-237, 1991.

 

Pasquale AD. Monforte MT. Calaro ML. HPLC analysis of oleuropein and some Flavonoids in leaf and bud of Olea europea L. II Farmaco, 46 :803-815,1991.

 

Keville K. OLIVE, Olea europaea, The American Herb Association, 13: 3-4, 1997.

 

 

 

 

 

כל האמור להלן הינו לידיעה כללית ואינו מהווה המלצה רפואית. 

לפני השימוש מומלץ לקרוא חומר נוסף ולהתייעץ עם אנשי מקצוע.

בכל מקרה של בעיה רפואית יש לפנות לרופא המטפל.

 

האתר נבנה במערכת 2all בניית אתרים